Fifth, the relatively small sample size of the subgroup, particularly the number of the participants with elevated hs-CRP levels, limited the ability of our analysis to identify traditional T2DM-related factors with small effect modification. The gene discussed is CRP; the disease is type 2 diabetes mellitus.